JP2025513920A5 - - Google Patents

Info

Publication number
JP2025513920A5
JP2025513920A5 JP2024561984A JP2024561984A JP2025513920A5 JP 2025513920 A5 JP2025513920 A5 JP 2025513920A5 JP 2024561984 A JP2024561984 A JP 2024561984A JP 2024561984 A JP2024561984 A JP 2024561984A JP 2025513920 A5 JP2025513920 A5 JP 2025513920A5
Authority
JP
Japan
Prior art keywords
disease
seq
galectin
vlp according
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024561984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513920A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/015132 external-priority patent/WO2023204148A1/en
Publication of JP2025513920A publication Critical patent/JP2025513920A/ja
Publication of JP2025513920A5 publication Critical patent/JP2025513920A5/ja
Pending legal-status Critical Current

Links

JP2024561984A 2022-04-18 2023-04-14 炎症性疾患の処置 Pending JP2025513920A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263332037P 2022-04-18 2022-04-18
US63/332,037 2022-04-18
PCT/JP2023/015132 WO2023204148A1 (en) 2022-04-18 2023-04-14 Treatment of inflammatory conditions

Publications (2)

Publication Number Publication Date
JP2025513920A JP2025513920A (ja) 2025-04-30
JP2025513920A5 true JP2025513920A5 (https=) 2026-03-26

Family

ID=88308716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024561984A Pending JP2025513920A (ja) 2022-04-18 2023-04-14 炎症性疾患の処置

Country Status (5)

Country Link
US (1) US20230330209A1 (https=)
EP (1) EP4511479A1 (https=)
JP (1) JP2025513920A (https=)
CN (1) CN119546752A (https=)
WO (1) WO2023204148A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118812696A (zh) * 2024-08-21 2024-10-22 南通大学附属医院 Galectin-3抗原表位肽、抗原、抗体及化学发光试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9969986B2 (en) * 2014-08-08 2018-05-15 Vlp Therapeutics, Llc Virus like particle comprising modified envelope protein E3
EP4326858A4 (en) * 2021-04-23 2025-03-12 VLP Therapeutics, Inc. GALECTIN-TARGETED IMMUNOTHERAPY

Similar Documents

Publication Publication Date Title
Denis et al. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization
JP6557208B2 (ja) Ｐｄ−１抗原またはｐｄ−１リガンド抗原を含むウイルス様粒子
CN114685626B (zh) Cmv的修饰病毒样颗粒
JP5065024B2 (ja) Ｔｃ−８３由来アルファウイルスベクター、粒子および方法
CA2405438A1 (en) Hepatitis b core antigen fusion proteins
JP2017523796A (ja) 修飾エンベロープタンパク質ｅ３を含むウイルス様粒子
Hyakumura et al. Modification of asparagine-linked glycan density for the design of hepatitis B virus virus-like particles with enhanced immunogenicity
CN116082521A (zh) 痘病毒多抗原嵌合疫苗及其用途
JP2010510960A (ja) 抗原の順序付けられた分子提示、提示の方法、および使用
Freivalds et al. Assembly of bacteriophage Qβ virus-like particles in yeast Saccharomyces cerevisiae and Pichia pastoris
JP2025513920A5 (https=)
JP5560510B2 (ja) カプシドタンパク質及びその利用
JP6863966B2 (ja) 標的ポリペプチドを提示するためのポリペプチド担体及びその使用
JP2024519195A5 (https=)
JP2018533908A5 (https=)
AU2010268694A1 (en) A method of preparation of a biological particulate structure
JP2024523329A5 (https=)
CA2597878A1 (en) Capsid protein and use therefore
CN110204613B (zh) 一种针对胡宁病毒的中和抗体、其制备方法及其应用
CA2996497C (en) Polypeptide carrier for presenting target polypeptide and uses thereof
JP2021522864A5 (https=)
HK40077650A (zh) Cmv的修饰病毒样颗粒
HK1252980B (en) Polypeptide carrier for presenting target polypeptide and uses thereof
LV15190B (lv) Paņēmiens tukšu un ar nukleīnskābēm pildītu hepatīta B vīrusa core-proteīna kapsīdu iegūšanai
HK1255670B (zh) Cmv的修饰病毒样颗粒